Back to search results

Data Collection Using Eko Digital Devices for Lung Sounds

This study is collecting information using Eko digital stethoscopes (Eko CORE 500 and 3M Littmann CORE Digital Stethoscope) to help develop an artificial intelligence (AI) program. This AI program aims to identify different types of abnormal lung sounds, like wheezing or crackles, in adults. Clinicians will use these digital stethoscopes during routine check-ups to record both normal and abnormal lung sounds from patients with or without lung conditions. The goal is to see if the AI can accurately detect these sounds and connect them to specific lung problems. You can join if you have a suspected or diagnosed lung condition, or if you have certain lung sounds like wheezing or crackles. People with normal lung sounds can also participate. This is an observational study, meaning you won't receive a new treatment, but your lung sounds will be recorded as part of your usual care. The study plans to enroll 250 people.

Study design
This is an observational study that plans to enroll 250 participants. It is not specified if it is randomized or blinded.
What's involved
You would have multiple recordings taken on your chest and back using Eko digital stethoscopes as part of your standard medical care.
Compensation
Not stated in the trial record.
Follow-up
Your participation will last through study completion, which is an average of 8-9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07227376

Data Collection Using Eko Digital Devices in a Clinical Setting

Recruiting
Not specifiedAll AgesObservational
Eko Devices, Inc.
~250 participants
Updated 2026-05-26 on ClinicalTrials.gov
What's tested:Eko digital stethoscopes

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Primary Objective
Measured over Through study completion, an average of 8-9 months

Conditions

Lung Diseases

Explore related trials

Lung Disorder

Where it's being run

2 sites across 2 states
Florida1
Pennsylvania1

Who to contact

Clinical Research Associate
[email protected]
8443563384
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Suspected or diagnosed lower respiratory condition OR Presence of wheeze, coarse crackle, fine crackle, rhonchus, stridor, rales, and cough discovered during routine auscultation
Normal patients with no adventitious lung sounds
Adults and pediatric patients (as available)

Exclusion

Unable to have multiple recordings taken on chest and back (e.g. compromised mobility)
On mechanical ventilation

What this trial measures

  • Primary ObjectiveThrough study completion, an average of 8-9 months

    The primary objective of this study is to collect normal and abnormal lung sounds of up to 750 patients per study site, by having clinicians use the Eko CORE and/or Eko CORE 500 device(s) in real clinical settings, as part of standard of care clinical practice which will then be used to explore an ML algorithm for classifiers for wheeze, coarse crackle, fine crackle, rhonchus, stridor, rales, and cough, as well as determine any correspondences between the type and/or location of adventitious lung sounds and the type of pulmonary conditions as reported by clinicians.